Global Update of the 2010 GIVS Goals
|
|
- Colin Berry
- 5 years ago
- Views:
Transcription
1 Global Update of the 2010 GIVS Goals Global Immunization Meeting New York, Feb 2009 JM Okwo-Bele, WHO P. Salama, UNICEF
2 Projected Changes in Under-5 yr mortality due to VPDs M illio n s Not preventable by Preventable with current pace of progress with coverage improvements Preventable if coverage is scaled up to 90%, impact of campaigns and widespread use of new vaccines %-70% reduction in rate
3 Are we on track to achieve the GIVS goals? 1. By 2010 or earlier - Increase coverage
4 Global DTP3 coverage and projections to reach 90% global goal in % coverage Global African American Eastern Mediterranean European South East Asian Western Pacific Source: WHO/UNICEF coverage estimates , August WHO Member States. Date of slide: 15 February 2008
5 Countries achieving >=90% DTP3 coverage, 2007 Source: WHO/UNICEF coverage estimates , August WHO Member States. Date of slide: 12 February t 2008 >=90% (117 countries or 61%) <90% (76 countries or 39%) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved
6 Countries with all districts achieving at least 80% DTP3 coverage, 2007 Source: WHO/UNICEF estimates and WHO/IVB database, September WHO Member States. Yes (55 countries or 28%) No (96 countries or 50%) No data (42 countries or 22%) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved
7 Countries with most unvaccinated infants DTP3 coverage, (in millions) India Nigeria China Indonesia Ethiopia Pakistan Uganda Niger Bangladesh DR Congo Major Concern: Lack of progress to reduce the number of un-reached Source: WHO/UNICEF coverage estimates , August 2008 Date of slide: 21 August 2008
8 "Return Routine Immunization to Issues: the centre stage" (*) Coverage data quality Political support in 'Lagging' Countries Cash support Ways forward: Return to the basics: Annual Planning & Reviews; training; improved monitoring Focus on the un-reached Support the current momentum for HSS/PHC Innovative & local solutions tailored to local needs (*) WHO/AFRO Medium Term Review_08)
9 Are we on track? 2. By 2010 or earlier Reduce Measles Mortality
10 Estimated measles deaths 2000, : deaths 2007 : deaths = 1000 death Dots are randomly distributed in countries. Data source: WHO/IVB, November 2008 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved
11 Status of Measles Control Reaching the 90% global measles reduction goal by 2010 requires : India starts catch up campaigns Improved measles coverage for both routine and follow up campaigns Political support Adequate funding
12 Global TT2 coverage and Estimated PAB % of target group Women with TT2+ in TT SIAs (in millions) WCBA SIA Protected Reported TT2+ cov PAB Estimates
13 Polio Eradication: New Strategic Plan Wild Poliovirus*, 11 Aug Feb 2009 Active conflict Insecurity & governance Wild virus type 1 Wild virus type 3 Political & societal buy-in Optimizing vaccination efficacy Endemic countries Case or outbreak following importation (0-6 months)
14 Critical to achieve soonest the disease initiatives goals Key issues Credibility at stake Waning commitment Ways forward Predictable funding necessary Commit resources for increased routine coverage in the un-reached AEFI risk assessment, prevention and management Expand Case-based surveillance and labnet
15 Are we on track? 3. By 2015 or earlier Introduce new vaccines
16 Global coverage estimates, DTP3, HepB3 and Hib % coverage DTP3 HepB3 Hib3 Source: WHO/UNICEF coverage estimates , August 2008, 193 WHO Member States.
17 Countries having introduced Hib vaccine and infant Hib coverage, 2007 The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. WHO All rights reserved Source: WHO/UNICEF coverage estimates , August 2008 Hib3 > 80% (94 countries) Hib3 < 80% (19 countries) Hib vaccine introduced but no coverage data reported (2 countrie Hib vaccine not introduced (78 countries)
18 Implementation of other new vaccines Japanese Encephalitis Yellow Fever Rubella Pneumo (Conjugate vaccines) Rotavirus Diarrhoea Typhoid Fever HPV Mening Conjugate A
19 Issues Accelerating the widespread use of new vaccines Complex decision-making processes Costs of new vaccines, a major barrier Need to reach the un-reached Ways forward Adjust timelines of WHO Recommendations Support routine immunization coverage (cold chain & logistics, planning ) Cost reduction strategies Vaccine presentations / Supply
20 The work ahead of us!
21 World Health Assembly Resolution on GIVS report, 24 May 2008 (WHA61.15) Concerned that many developing countries are not on track to meet health-related MDG Goals, particularly the target of reducing the under-five mortality rate URGES Member States: (1) to implement fully the strategy for reducing measles mortality (2) to improve delivery of high-quality immunization services (and) achieve equitable coverage of at least 80% in all districts by 2010; (3) to stimulate rapid introduction of new vaccines in accordance with national priorities and to expand coverage of these vaccines;
22 In brief, all immunization stakeholders should help to Focus on the "lagging" countries Minimize the imbalance in attention and funding for: Routine Immunization Accelerated Disease Control Initiatives New Vaccines Introduction Improve collaboration in support of the foundation of immunization!
23 END
24 Part 3: Linking Immunization With Other Interventions
25 Getting Results Over the past 50 years childhood deaths have dropped dramatically. The number of children born went up, while the number who died was cut in half. I think this is one of the most amazing statistics ever Bill Gates in his first annual letter on the work of BMGF, January 2009
26 Trends in Global Under 5 Mortality, Number of <5 deaths
27 Annual <5 Deaths Decline to 9.2 Million
28 Where Did Children Die in 2007? 10,000 deaths
29 Coverage Along the Continuum of Care Source: Lancet Countdown Coverage writing group, Lancet Countdown special issue, 2008
30 Malaria Funding By GFATM Round $3,000,000,000 $2,500,000,000 In te n s ifie d UNIC E F a n d p a r tn e r s u p p o rt to p ro p o s a l p ro c e s s $2,000,000,000 $1,500,000,000 $1,000,000,000 $500,000,000 $0 Rd R d Rd
31 Number LLINs Distributed and Projected, Campaign Size Cumulative LLINs GF R8 Ph I funds begin Togo EQ. Guinea Zambia Eritrea Kenya Rwanda S. Leone Ghana Zambia Ethiopia Cameroon Nigeria Madagascar Gabon Equ Guinea Congo-B Angola Burundi DRC Congo Liberia Senegal Tanzania Togo Cameroon Guinea Kenya Zimbabwe CAR Sudan N Niger Gambia Madagascar Benin Note: Data from is estimated and/or being confirmed
32 Trends in ITN Coverage, Swaziland '00 - '06-'07 Côte d'ivoire '00 - '06 Sierra Leone '00 - '05 DRC '01 - '07 Kenya '00 - '03 Niger '00 - '06 Burundi '00 - '05 Uganda '00-'01 - '06 Burkina Faso '03 - '06 Cameroon '00 - '06 Rwanda '00 - '05 CAR '00 - '06 Senegal '00 - '06 Benin '01-'02 - '06 Ghana '03 - '06 Malawi '00 - '06 Tanzania '99 - '07-'08 Zambia '99 - '07 Ethiopia '05 - '07 Togo '00 - '06 Guinea-Bissau '00 - '06 Sao Tome/Principe '00 - '06 Gambia '00 - '06 Source: UNICEF Global Databases, November 2008
33 Trends in Malaria Cases and Deaths in Relation to Interventions, 4 African countries, (NMCP/WHO data)
34 Countries Conducting Child Health Days, 2007 Countries conducting CHD in 2007 twice a year (UNICEF)
35 Coverage with EOS/CHDs VS Routine EPI By Region in Ethiopia, UNICEF 2006 SNNPR Tigray Addis Ababa Amhara Oromiya Harari Afar Dire Dawa Benshangul Gumz Gambella Somali Admn DPT3 coverage Vit A coverage Deworming coverage Measles SIA coverage
36 ACSD Evaluation: Results of Integration of EPI With Other Interventions Benin Ghana Mali Measles * * DPT * * Vitamin A * * * ITNs 6 Source: ACSD evaluation, JHSPH 26 * Increases in coverage across the board in Ghana and Mali; Benin achieved increases for vitamin A * Change was significant at p < and ITNs. * * Key Before ACSD After ACSD
37 Challenges With Child Health Days Too many interventions Some interventions inadequate for campaign delivery Routine dose of antigens are mostly not part of CHD Insufficient monitoring of coverage by intervention Insufficient documentation Funding not yet sustainable
38 % of coverage (IPTi / EPI) Dec IPTi Integration Into EPI Intermittent Preventive Treatment of Malaria at DTP2, DTP3 and measles Jan Mars Madagascar Apr Feb Benin May Ghana Apr Jun Jul Jun Aug Sept Aug Oct Dec Malawi Feb Mali Apr Jun Dec Feb Apr Jun Nov Jan Senegal Mars May Jul Sept IPTi1/ DTP2 IPTi2/ DTP3 IPTi3/ Measles
39 Cotrimoxazole (CTX) for HIV Exposed Infants Initiation of CTX for HIV-exposed infants at DTP1 DTP1 coverage: >90% in most countries CTX Regimen: ¼ to 2 tablets (depending on age and formulation) once per day Child health cards can prompt initiation at DTP1 contact and follow-up
40 Co-trimoxazole Treatment Initiated at DPT1 Contact and Continued for 8 Months EID and CTX, Swaziland, January - August, Number Exposed children 2007: 6% coverage in : 55% coverage at 8 months Early infant diagnosis 600 Testing positive CTX
41 Cause of Deaths Among Under Fives Other, 10% Injuries, 3% HIV/AIDs, 3% Measles, 4% Neonatal, 37% Malaria, 8% Under-nutrition (underlying cause) Diarrhea, 17% Source: 2005 World Health Report Pneumonia, 19%
42 Coverage Along the Continuum of Care GAP 1 GAP 2 GAP 3 Source: Lancet Countdown Coverage writing group, Lancet Countdown special issue, 2008
43 Proportion of Children <5 with Suspected Pneumonia Taken to Appropriate Health Provider Source: DHS, MICS & other national surveys
44 And poorest have least access Bangladesh: Equity in Pneumonia Interventions Between poorest and wealthiest quintiles Excl BF 0-5 mos Measles vaccine Full vaccine coverage Vit A supp (within last 6 mos) Handwashing Careseeking behavior Amoxicillin for pneumonia Source: MICS 3, 2006 Coverage (%) of interventions
45 How Could EPI Contribute to Pneumonia Control? Sustain protection against measles with 2 doses Introduction of new and underutilized vaccines (PCV and Hib) Implementation of integrated package using RED: Focused health system strengthening approach Community-Case Management, Promotion of EBF and Handwashing, Vitamin A Challenges to consider? Joint fundraising/leveraging? Joint planning? Joint supply management of vaccines and antibiotics? Joint monthly monitoring? Integrated surveillance?
46 Optimal Management of Diarrhea Approved in 2003 Recommended for all cases of acute diarrhea: 1. Low osmolarity ORS 2. Oral zinc sulfate 20 mg daily for 14 days 3. Antibiotics in dysentery No country has as yet implemented this strategy at scale
47 Part 4: Global Interdependence
48 Global Interdependence If we lose sight of our long-term priority to expand opportunity for the world s poor and abandon our commitments and partnerships to reduce inequity, we run the risk of emerging from the current economic downturn in a world with even greater disparities in health and education and fewer opportunities for people to improve their lives. Bill Gates, Davos, 2009
49 Price Reduction in DTP-HepB, DTP-HepB: Procured ( ) & PQ offers ( ) -Associated Factors: -Multiple suppliers in the market -Manufacturers from developing country -Long term funding through GAVI Number of doses (millions) $1.40 $1.20 $1.00 $0.80 $0.60 $0.40 USD $ $0.00 Weighted average price PQ products Pipeline products
50 Are the Same Conditions Present for DTP HepB Hib? -Growth in demand -Multiple suppliers -In the pipeline: developing country suppliers -Long term funding through GAVI Weighted average price PQ products Pipeline products
51 GIVS: Total Costs, Poorest Income Countries 45 Low and Middle Income Countries Total $ 27.9 billion $ 30.6 billion $ 58.5 billion Campaign costs (vaccines % operational costs) 3% Additional costs to reach routine targets 20% System costs maintaining current coverage 40% Traditional vaccines (routine) 7% Underused vaccines (routine) 15% New vaccines (routine) 15%
52 GIVS Funding Gap for 72 Poorest Countries Funding Scenario ( ) ** 72 Poorest Countries Best Case Worst Case US$ Bn US$ Bn National Governments* $13.5 $11.0 GAVI Fund* $7.4 $4.6 Mulitlaterals (WHO & UNICEF)* $1.8 $0.6 Other $0.9 $0.4 Funding Gaps $4.4 $11.3 Unmet needs (% of requirements) 15.6% 40.6% * Includes contributions from bilateral agencies ** Extrapolated from the funding scenarios of 50 of the 72 countries based on their 5 year multi-year plan for immunization (cmyp)
53 Conclusions Focus on sustaining gains and reaching the unreached to achieve existing goals Continue to pursue linkages with child survival interventions through pro-poor outreach and facility-based strategies Use introduction of new vaccines as a major opportunity to revitalize programming for pneumonia and diarrhoea Utilize RED approach and EPI planning, supply chain management and monitoring tools for broader systems strengthening goals Integrate with national planning and budget cycles as part of revitalization of PHC
IMMUNIZATION VACCINES & EMERGENCIES
No report No data No data IMMUNIZATION VACCINES & EMERGENCIES ROUTINE IMMUNIZATION PERFORMANCE IN THE AFRICAN REGION October 2013 issue Number of children vaccinated with the 3 rd dose of DTPcontaining
More informationGlobal Immunization Vision and Strategies (GIVS) Vaccine Tender , Pretender Meeting, Copenhagen December 2008
Global Immunization Vision and Strategies (GIVS) 2006-2015 Vaccine Tender 2010-2012, Pretender Meeting, Copenhagen 10-11 December 2008 Dr Ahmed Magan & Dr Osman David Mansoor Programme Division UNICEF
More informationCONTENTS. Paragraphs I. BACKGROUND II. PROGRESS REPORT ON THE AFRICAN REGIONAL IMMUNIZATION STRATEGIC PLAN
23 September 2013 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-third session Brazzaville, Republic of Congo, 2 6 September, 2013 Agenda item 14 IMMUNIZATION IN THE AFRICAN REGION: PROGRESS REPORT
More informationPROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS
29 June 2009 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, 31 August 4 September 2009 Provisional agenda item 9.2 PROGRESS REPORT ON CHILD SURVIVAL: A
More informationGlobal reductions in measles mortality and the risk of measles resurgence
Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there
More informationGlobal Immunization Overview. Thomas Cherian Expanded Programme on Immunization WHO, Geneva
Global Immunization Overview Thomas Cherian Expanded Programme on Immunization WHO, Geneva Global U5 Mortality: Role of Vaccine Preventable Diseases (2008 data) 8.8 million under five deaths Other 20%
More informationUpdate from GAVI Aurelia Nguyen
Update from GAVI Aurelia Nguyen (Copenhagen, Denmark, 27 June 2012) GAVI vaccine support Currently supported vaccines: pentavalent, pneumococcal, rotavirus, meningitis A, human papillomavirus (HPV), rubella,
More informationThe Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007
History & Future of the Expanded Programme on Immunization Supplier Meeting, Copenhagen, 3-4 April 2008 Dr Osman David Mansoor Senior Adviser EPI (New Vaccines) UNICEF New York The Gates Challenge If we
More informationWild Poliovirus*, 03 Aug 2004 to 02 Aug 2005
Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005 Wild virus type 1 Wild virus type 3 Wild virus type 1 & 3 Endemic countries Re-established transmission countries Case or outbreak following importation *Excludes
More informationIMMUNIZATION & VACCINE PREVENTABLE DISEASES
IMMUNIZATION & VACCINE PREVENTABLE DISEASES MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2015 (Vol 3, issue N 6 ) Special issue on WHO/UNICEF Estimates of National Immunization Coverage
More informationPOLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12
5 August 9 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-ninth session Kigali, Republic of Rwanda, August 4 September 9 POLIOMYELITIS ERADICATION: PROGRESS REPORT Information Document CONTENTS
More information1) SO1: We would like to suggest that the indicator used to measure vaccine hesitancy be DTP 1 to measles first dose dropout.
To SAGE Secretariat, WHO Dear Professor Helen Rees, Dear Dr. Jean Marie Okwo-Bele, On behalf of the Civil Society Constituency of the GAVI Alliance, we would like to thank SAGE and its members for the
More informationFrom development to delivery: Decision-making for the introduction of a new vaccine
From development to delivery: Decision-making for the introduction of a new vaccine Prince Mahidol Award Conference Bangkok, Thailand 1-2 February 2007 Dr. J.M. Okwo-Bele Department of Immunization, Vaccines
More informationPrioritizing Emergency Polio Eradication Activities
Prioritizing Emergency Polio Eradication Activities Managing the Financing Gap the other half of the Emergency Hamid Jafari GPEI Financing 2012-13: Budget = $2.23 b - Confirmed contributions = $1.14 b
More informationTT Procured by UNICEF
TT TT Procured by UNICEF 2001-08 250,000,000 200,000,000 150,000,000 100,000,000 50,000,000 0 2001 2002 2003 2004 2005 2006 2007 2008 Routine SIA TT historical demand and forecast overview Upcoming Tender
More informationMalaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA
Malaria Funding Richard W. Steketee MACEPA, PATH April World Malaria Day 2010, Seattle WA Malaria Funding Is there a plan? Is there money? Where does the money come from? Is the money moving efficiently?
More informationNO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns
NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL Measles & Rubella Campaigns With fewer than 600 days remaining to the Millennium Development Goal (MDG) deadline,
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION UPDATE IN THE AFRICAN REGION July-August 2016 (Vol 4, issue N 5) Special issue on 2015 WHO/UNICEF Estimates of National Immunization Coverage (WUENIC)
More informationHPV Vaccine Lessons Learned & New Ways Forward
HPV Vaccine Lessons Learned & New Ways Forward The Gavi Alliance June 2016, Geneva www.gavi.org Overview 1 Background 2 Lessons learned 3 New Way Forward 2 1 Background 3 HPV Background HPV is responsible
More informationThe Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control
The Promise of Introducing Rubella Containing Vaccines on the Impact of Rubella and Measles Control GAVI Partners Forum 4 6 December 2012, Dar es Salaam, Tanzania Maya van den Ent, MPH, UNICEF Peter Strebel,
More informationCEO Board report Seth Berkley MD CEO
CEO Board report Seth Berkley MD CEO Dhaka, Bangladesh, 16 17 November 2011 Bangladesh, November 2011 Meningitis Incidence Children < 12 months Dhaka Shishu / Shishu Shahsta Catchment Area 2008 2011 1800
More informationTFI Proceedings, Recommendations and implications for 2005
January 2005 N 053 TFI 2004 - Proceedings, Recommendations and implications for 2005 The 12th meeting of the Task Force on Immunization (TFI) in Africa and the 11th meeting of the Africa Regional Inter-
More informationMarket Updates: Routine Vaccine Introductions IPV. Vaccine Industry Consultation October 2018 UNICEF Supply Division
Market Updates: Routine Vaccine Introductions IPV Vaccine Industry Consultation October 2018 UNICEF Supply Division Outline Review of rapid introduction of IPV Overview of the current situation for 2018
More informationUpdate from the GAVI Alliance Seth Berkley, MD Chief Executive Officer
Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer SAGE meeting Geneva, 8-10 November 2011 Topics to cover Update on new vaccine introduction Introductions New approvals Co-financing
More informationGavi s strategic framework 22 June 2016
Gavi s 2016 2020 strategic framework 22 June 2016 Gavi 2000-2015 Gavi 3.0 Gavi 2.0 250 million children immunised Gavi 1.0 90m children immunised 200 million children immunised 2000 2005 2006 2010 2011
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT MONTHLY IMMUNIZATION AND POLIO UPDATE IN THE AFRICAN REGION January February 2017 (Vol 5 issue N 1) District data completeness and coverage of DTP3 containing vaccine per
More informationMaternal and Neonatal Tetanus Elimination by Yes, We Can! Global Immunization Meeting 18 th February 2009
Maternal and Neonatal Tetanus Elimination by 2012 Yes, We Can! Global Immunization Meeting 18 th February 2009 OUTLINE Can we eliminate MNT by 2012? Can MNTE contribute to MDG4? Can TT-SIAs help to deliver
More informationAboubacar Kampo Chief of Health UNICEF Nigeria
Aboubacar Kampo Chief of Health UNICEF Nigeria Many thanks to UNICEF colleagues in Supply Division-Copenhagen and NY for contributing to this presentation Thirty-five countries are responsible for 98%
More informationUpdate on Progress and Challenges in Achieving Measles and Rubella Targets
Update on Progress and Challenges in Achieving Measles and Rubella Targets SAGE Meeting 6 November 2013 P. Strebel, WHO/IVB/EPI Overview Global progress Regional updates Summary 2 Measles and Rubella Targets
More informationVPD in Mediterranean Basin and Black Sea: the Polio case
Screening practices for infectious diseases among newly arrived migrants and Vaccine Preventable Disease (VPD): strategies and coverage ISS 29 MAY 2015 VPD in Mediterranean Basin and Black Sea: the Polio
More informationWhat is this document and who is it for?
Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination
More informationImmunization Update & focus on meningococcal vaccine PART 1
Immunization Update & focus on meningococcal vaccine PART 1 Gregory Hussey Vaccines for Africa Initiative Institute of Infectious Diseases University of Cape Town www.vacfa.uct.ac.za Disclosures Received
More informationPneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division
Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook UNICEF Supply Division Update: October 2013 0 Pneumococcal Conjugate Vaccine (PCV) Supply & Demand Outlook October 2013 Update Key updates
More informationANNEX Page. AFR/RC61/11 4 July 2011 ORIGINAL: ENGLISH REGIONAL COMMITTEE FOR AFRICA
4 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 16 PROGRESS REPORT ON POLIOMYELITIS ERADICATION
More informationMeasles and Rubella Global Update SAGE 19 October 2017
Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella
More informationOverview of WHO/UNICEF Immunization Coverage Estimates
Overview of WHO/UNICEF Immunization Coverage Estimates Marta Gacic-Dobo, Anthony Burton, David Durrheim Meeting of the Strategic Advisory Group of Experts on Immunization (SAGE) 8-10 November 2011 CCV/CICG,
More informationPROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA
5 July 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 17.1 PROGRESS REPORT ON THE ROAD MAP FOR
More informationYellow fever Vaccine investment strategy
Yellow fever Vaccine investment strategy Background document #5 November 2013 Executive summary Since 2001, GAVI has spent ~$250M on yellow fever control $102M on routine vaccination in 17 countries ~$160M
More informationUSAID Progress: The U.S. National Vaccine Plan of 1994
USAID Progress: The U.S. National Vaccine Plan of 1994 Ellyn Ogden Neal Brandes Angela Weaver Washington DC March 3, 2008 Objective 1.1/1.5 (New Vaccines) Support to GAVI for introduction of new vaccines
More informationStatus of Outbreak Vulnerable Countries
Status of Outbreak Vulnerable Countries Hamid Jafari, WHO Robert Linkins, CDC Independent Monitoring Board Meeting 7-8 May, 2013 Outline Non-Endemic Vulnerable & At-Risk Countries Recently infected countries
More informationMEASLES ELIMINATION BY 2020: A STRATEGY FOR THE AFRICAN REGION. Report of the Secretariat. Executive Summary
16 June 2011 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-first session Yamoussoukro, Côte d Ivoire, 29 August 2 September 2011 Provisional agenda item 13 MEASLES ELIMINATION BY 2020: A STRATEGY
More informationPneumococcal Vaccine Introductions Dr. Carsten Mantel WHO/FCH/IVB/EPI
Pneumococcal Vaccine Introductions 2012 Dr. Carsten Mantel WHO/FCH/IVB/EPI Pneumonia is leading cause of death in children < 5 yrs * Pneumococcus and Hib are the two leading causes of life-threatening
More informationFighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010
Fighting Harder and Smarter Against Malaria Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010 Outline Burden of malaria Global support for rolling back malaria
More informationGlobal landscape analysis and literature review of 2 nd Year of Life immunization platform
Global landscape analysis and literature review of 2 nd Year of Life immunization platform Global Vaccine and Immunization Research Forum 15-17 March 2016 Johannesburg, South Africa Imran Mirza; Celina
More informationGlobal Report to SAGE. Fulfillment of previous recommendations & progress highlights
Global Report to SAGE Fulfillment of previous recommendations & progress highlights SAGE Meeting, 8-10 November 2012 J.M. Okwo-Bele, WHO Outline 1 2 3 4 Global progress Regional updates- RTAGs recommendations
More informationCOLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)
COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP) Sushila Maharjan Senior Manager, Innovative Finance International Conference on Sustainable Cooling World Bank Washington DC - 29 November 2018 Reach
More informationExpanded Programme on Immunization (EPI)
Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles
More informationGAVI RESOURCE GAP ALWAYS BEEN AN ISSUE
GAVI RESOURCE GAP ALWAYS BEEN AN ISSUE 1 Phasing in (an early diagram) 5 year Vaccine Fund commitment extended over 8 year phase- Countries will be notified of 5 year Vaccine Fund commitment Investments
More informationDevelopment of the Polio Eradication and Endgame Strategic plan
Development of the Polio Eradication and Endgame Strategic plan SAGE Meeting 6 November 2012 Overview Process, Consultations, Development Eradication and Endgame Outcomes and Activities Legacy Planning
More informationFunding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia
Funding for AIDS: The World Bank s Role Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia Outline New resources needs estimates Bridging the gap Global overview of
More informationTotal population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
More informationChildren in Africa. Key statistics on child survival, protection and development
Children in Key statistics on child survival, protection and development Key Statistics In, mortality rates among children under five decreased by 48 per cent between 199 and 13, but still half of the
More informationRotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division
Rotavirus Vaccine: & Demand Update UNICEF Division July 0 Rotavirus Vaccine (RV): & Demand Update July This update provides new information on countries and their scheduled RV introductions, forecasted
More informationPoliovirus : éradication pour les prochaines JNI?
Poliovirus : éradication pour les prochaines JNI? Bruno LINA CNR des entérovirus Laboratoire de virologie EST, GHE, HCL FRE 3011 CNRS UCBL, Lyon Polio Eradication Initiative 1 Polio Eradication Progress
More information511,000 (57% new cases) ~50,000 ~30,000
Latest global TB estimates - 2007 (Updated Mar 2009) All forms of TB Greatest number of cases in Asia; greatest rates per capita in Africa Multidrug-resistant TB (MDR-TB) Estimated number of cases 9.27
More informationPOLIO ERADICATION AND POST-CERTIFICATION STRATEGY
POLIO ERADICATION AND POST-CERTIFICATION STRATEGY PRE-BOARD MEETING 5 June 2018, Geneva Reach every child www.gavi.org Agenda Topic Presenter 1. Polio eradication update WHO 10 minutes 2. IPV supply, demand
More informationIMMUNIZATION VACCINE DEVELOPMENT
IMMUNIZATION VACCINE DEVELOPMENT IMMUNIZATION AND POLIO UPDATE IN THE AFRICAN REGION July August 2017 (Vol 5 issue N 4) Special issue featuring WHO/UNICEF Estimates of National Immunization Coverage (WUENIC
More informationVaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA
TM Vaccines against Rotavirus & Norovirus Umesh D. Parashar CDC, Atlanta, GA 1 Rotavirus is the Leading Cause Of Severe Diarrhea in Children
More information40 years of childhood vaccination programmes in Africa. Mind the gap
40 years of childhood vaccination programmes in Africa Mind the gap Charles Shey Umaru Wiysonge MD, MPhil, PhD, MASSAf Centre for Evidence-based Health Care, Stellenbosch University, South Africa Email
More informationGlobal Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
More informationOuagadougou Declaration
Ouagadougou Declaration on Primary Health Care and Health Systems in Africa: Achieving Better Health for Africa in the New Millennium A declaration by the Members States of the WHO African Region 30 April
More informationUpdate on Meningococcal A Vaccine Development and Introduction
Update on Meningococcal A Vaccine Development and Introduction WHO Product Development for Vaccines Advisory Committee Meeting (PD-VAC) @ Geneva, 7-9 September 2015 Dr Marie-Pierre Preziosi, WHO Initiative
More informationTotal population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100
Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing
More informationAnnex 2 A. Regional profile: West Africa
Annex 2 A. Regional profile: West Africa 355 million people at risk for malaria in 215 297 million at high risk A. Parasite prevalence, 215 Funding for malaria increased from US$ 233 million to US$ 262
More information宮村参考人提出資料 資料 2-2
宮村参考人提出資料 資料 - Highlights of New Wild Poliovirus and cvdpv Positives Reported Globally this Week WPV cvdpv AFP other AFP other Afghanistan 5 Pakistan 3 Nigeria Location: state/province/governorate Kunar
More informationAccess to vaccination in GAVI countries and at global level
Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for
More informationHarnessing the power of vaccines using the public and private sector: A 21 st century model for international development
Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development Dr. Seth Berkley, CEO GAVI Alliance Wellcome Trust Cambridge Centre for Global
More informationMaternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York
Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York Copenhagen, Denmark 23 September 2013 Visit www.everywomaneverychild.org
More informationTotal population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093
DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal
More informationTotal population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
More informationPOLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY
7 July 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-sixth session Addis Ababa, Ethiopia, 28 August 1 September 2006 Provisional agenda item 10.1 POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS
More informationTask Force on Immunization (TFI) in Africa 14 th Annual Meeting. And. Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting
Task Force on Immunization (TFI) in Africa 14 th Annual Meeting And Africa Regional Inter-Agency Coordination Committee (ARICC) 13 th Annual Meeting Meeting Report Maputo, Mozambique 27 29 November 2006
More informationStrategies to Control Pneumonia and Diarrhoea: Tackling the deadliest diseases for the world s poorest children
Strategies to Control Pneumonia and Diarrhoea: Tackling the deadliest diseases for the world s poorest children Dr. Mark W. Young Senior Health Specialist UNICEF Programme Division New York September 24,
More informationEvaluating the acceptability of vaccine and vaccination programmes: an individual and public health perspective
The regulatory process Evaluating the acceptability of vaccine and vaccination programmes: an individual and public health perspective Annecy, Les Pensières July 7-9, 2008 Dr. Nora Dellepiane, Scientist
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationAIDS in Africa. An Update. Basil Reekie
AIDS in Africa An Update Basil Reekie Contents General Statistics The trend of HIV in Africa Ugandan experience UNAIDS 2006 Latest African Statistics by Country HIV Intervention Light at the end of the
More informationUpdate on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI
Update on Implementation of NUV Carsten Mantel WHO/FCH/IVB/EPI Introduction of New Vaccines The continuum of activity REGULATORY NORMS & STANDARDS VACCINE SUPPLY PROCUREMENT PRICING FINANCING SURVEILLANCE
More informationCDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN
CDC ASSESSMENT OF RISKS TO THE GLOBAL POLIO ERADICATION INITIATIVE (GPEI) STRATEGIC PLAN 2010-2012 14 Sept-10 2010 First and Second Quarters (January June) Geographic distribution of wild poliovirus (WPV)
More informationHealth systems and HIV: advocacy. Interagency Coalition on AIDS and Development
Health systems and HIV: Priorities for civil society advocacy Michelle Munro Interagency Coalition on AIDS and Development 1 Overview GTAG, civil society and health systems advocacy Health systems and
More informationGAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS
GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing
More informationThe Financial Sustainability of New Vaccine Introduction in the Poorest Countries :
The Financial Sustainability of New Vaccine Introduction in the Poorest Countries : Evidence from the First Phase of GAVI (Global Alliance for Vaccines and Immunization) Patrick Lydon lydonp@who.int Session:
More informationDecade of Vaccines Global Vaccine Action Plan. GVAP Secretariat report 2015 Update actions on taken by the secretariat in response to previous reports
Decade of Vaccines Global Vaccine Action Plan GVAP Secretariat report 2015 Update actions on taken by the secretariat in response to previous reports Dr Thomas Cherian on behalf of the DoV GVAP Secretariat
More informationUNAIDS 2013 AIDS by the numbers
UNAIDS 2013 AIDS by the numbers 33 % decrease in new HIV infections since 2001 29 % decrease in AIDS-related deaths (adults and children) since 2005 52 % decrease in new HIV infections in children since
More informationObjective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch
Objective 2 Strengthening Routine Immunization, IPV introduction and the topv-bopv switch Polio Partners Group meeting Geneva 8 December 2014 Michel Zaffran Coordinator, WHO/EPI, IMG Co-chair On behalf
More informationASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare
ASLM Anti-microbial Resistance in Africa and Global Health Security 9TH INTEREST WORKSHOP 2015 8 May 2015 Harare Recent Jim O Neil Report commissioned by the UK government predicts dire consequences of
More informationRotavirus vaccines: Issues not fully addressed in efficacy trials
Rotavirus vaccines: Issues not fully addressed in efficacy trials TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines Licensed in 2006
More informationSUPPLEMENTARY APPENDICES FOR ONLINE PUBLICATION. Supplement to: All-Cause Mortality Reductions from. Measles Catch-Up Campaigns in Africa
SUPPLEMENTARY APPENDICES FOR ONLINE PUBLICATION Supplement to: All-Cause Mortality Reductions from Measles Catch-Up Campaigns in Africa (by Ariel BenYishay and Keith Kranker) 1 APPENDIX A: DATA DHS survey
More informationGlobal initiatives and priority products for MNCH
Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York Copenhagen, Denmark 22 September 2014 Reductions in absolute numbers of child deaths The total
More informationDebriefing on the External Retrospective Evaluation of ACSD
Institute for International Programs An international evaluation consortium ACCELERATING CHILD SURVIVAL AND DEVELOPMENT IN AFRICA (ACSD) Debriefing on the External Retrospective Evaluation of ACSD 19 February
More informationNeglected Tropical Diseases
Neglected Tropical Diseases 26-27 Achievements 28 Challenges Dr Lorenzo Savioli Director The Neglected Tropical Disease extended family Lymphatic filariasis Onchocerciasis Schistosomiasis Soil-transmitted
More informationVaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO
Vaccine Preventable Disease Surveillance: Overview Thomas Cherian, WHO Global Framework on Immunization Monitoring and Surveillance (GFIMS) l An extension of the GIVS, published on December 07 - http://www.who.int/immunization/en/
More informationScaling Up Nutrition Action for Africa
Scaling Up Nutrition Action for Africa Where are we and what challenges are need to be addressed to accelerate malnutrition? Lawrence Haddad Global Alliance for Improved Nutrition Why should African political
More informationOverview of Immunization & Child Health Integration Efforts
Overview of Immunization & Child Health Integration Efforts Tracey Goodman (IVB) & Samira Aboubaker (MCA) 3 April 2014, SAGE Geneva 1 Outline of Presentation Background and "EPI Plus" Evidence-base for
More informationFRAMEWORK FOR IMPLEMENTING THE GLOBAL STRATEGY TO ELIMINATE YELLOW FEVER EPIDEMICS (EYE), IN THE AFRICAN REGION. Report of the Secretariat
13 June 2017 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Sixty-seventh session Victoria Falls, Republic of Zimbabwe, 28 August 1 September 20177 Provisional agenda item 11 FRAMEWORK FOR IMPLEMENTING
More informationStatus Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa
Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa Ede Ijjasz Global Manager Water and Sanitation Program World Water Forum, Mexico, March 18, 2006 Outline 1. The Water Supply and
More information( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI
( A JICA-IRRI-PhilRice Initiative) Presented by Noel Magor, Head Unit Impact Acceleration and Training Center, IRRI Long partnership between; IRRI & PhilRice IRRI & JICA PhilRice & JICA The Season Long
More informationTable 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)
EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb
More informationEBOLA SITUATION REPORT
EBOLA SITUATION REPORT 11 FEBRUARY 2015 CASES/ DEATHS (data up to 8 February 2015) Guinea Liberia Sierra Leone Mali Nigeria Senegal Spain United Kingdom United States of America Total 8 6 20 8 1 0 1 0
More informationGlobal ProhrammeUpdate?
Global ProhrammeUpdate? Polio Partners Group Meeting, Geneva, 3 December 218 On behalf of the GPEI : Michel Zaffran, Director Polio Eradication, WHO / Chairman, GPEI Strategy Committee 1 WildPoliovirus
More informationEBOLA SITUATION REPORT
25 FEBRUARY 205 CASES/ DEATHS (data up to 22 February 205) Guinea Liberia Sierra Leone Mali Nigeria Senegal Spain United Kingdom United States of America Total 8 6 20 8 0 0 0 4 355 209 4037 346 9238 9604
More information